[ad_1]
The research department at the Cleveland Clinic Abu Dhabi is comprised of dedicated multidisciplinary research teams conducting studies aimed at reducing the impact of major diseases on community health.
The department has more than 200 active studies, 60 of which are starting in 2022. Research on key topics such as digestive disorders, neurological disorders and heart disease is sometimes conducted in collaboration with various other local and regional institutions.
Under the Abu Dhabi Department of Health’s efforts to improve overall healthcare for the people of the UAE, the hospital aims to use the research as part of its wider efforts, working with other partners to advance treatment options in the UAE and the GCC region as well as Abu Dhabi stakeholders.
three studies
Three ongoing studies focusing on liver health, breast cancer and obesity. All three studies were dedicated to the UAE population and used genome-based approaches, focusing on genomic or DNA data. With this approach, research results can be compared and validated to accelerate the development of new treatments and personalized healthcare solutions for these diseases. The Cleveland Clinic Abu Dhabi is urging the public to register as participants in future clinical trials to ensure the success of such efforts.
Dr Sawsan Abdel-Razig, Chief Academic Officer, Cleveland Clinic Abu Dhabi, M42, said: “Our mission at Cleveland Clinic Abu Dhabi is to provide world-class care to the UAE community and the wider region. Together, in teams, with universities and other strategic partners, to advance healthcare in communities.Through our broader education and research efforts, we are investing in the next generation of clinical nurses and healthcare leaders to develop new treatments, advanced diagnostic methods and preventive care options that will benefit the people of the UAE for years to come.”
The first of the three studies, conducted in collaboration with another M42 company, the Imperial College London Diabetes Centre, is the first prospective metabolic study of obesity, diabetes and fatty liver disease in the UAE population. In collaboration with Khalifa University, the second study explores obesity and bariatric surgery and is the first genetic study of metabolic disease.
Experimental Research
Finally, a pilot study of breast cancer health awareness among women in the UAE aimed to identify disease patterns in the local population and raise awareness of the need for regular mammograms.
All three studies aim to strengthen healthcare in the UAE and were made possible through the participation of numerous study participants. Research programs and studies at Cleveland Clinic Abu Dhabi comply with strict guidelines set by the Abu Dhabi Department of Health. Participants in these research projects will be treated with the highest standards of security and protected by the strictest confidentiality. — trade arab news agency
[ad_2]
Source link